Taking action against the global threat of antimicrobial resistance

The World Health Organization coordinates World Antibiotic Awareness Week each November. Dr Andrew Singer explains why the environmental dimension of AMR is a major concern...

The threat of antimicrobial resistance (AMR) to global public health has been a recurring fear over the past 77 years since the widespread use of penicillin and the 84 years since the use of sulfa-based antibiotics.

Chemicals in our wastewater...and our rivers - closing the water cycle loop

Dr Andrew Singer is leading CEH's research into antimicrobial resistance in the environment. Antimicrobials represent a small fraction of the chemicals that are continuously released into the environment from sewage works. However, their direct, negative impact on microorganisms (in the environment) provides a new motivation for examining the hazards within our waste stream, and its potential for effects on the environment and human health. Here he provides a perspective, first shared in the ENDS Report, which explains why change is needed in how we handle our wastewater.

AMR - investigating the knowledge gaps

The problem of antimicrobials in the environment has gained much prominence recently and it's a topic that the Centre for Ecology & Hydrology has been researching for many years. In 2009, an H1N1 influenza strain emerged from northern Mexico/southern United States and spread globally rapidly. The use of the antiviral oseltamivir (Tamiflu) in most high-income countries presented a unique environmental hazard—the widespread use of a novel drug in a short span of time.

Antimicrobial Resistance in the Environment

The World Health Organization is holding World Antibiotics Awareness Week this week (14-20 November 2016) to increase awareness of global antibiotic resistance and to encourage best practice among a number of sectors. Dr Andrew Singer of the Centre for Ecology & Hydrology has written the following blog post explaining some of the issues and current focuses of research:

Flu study offers unique insight into our drug habits during a pandemic

New research led by CEH’s Dr Andrew Singer provides the first evidence of how the use of antibiotic and antiviral drugs became elevated during the 2009-2010 influenza pandemic in the UK. The study, published in PLOS One, offers a unique look at public health practice, human behaviour and drug adherence in the country. Andrew tells us more:

Subscribe to RSS - Dr. Andrew C Singer's blog